Aotearoa’s first medically approved quit-vaping product
Aotearoa New Zealand has approved its first medical product to help people quit vaping, recognizing vaping dependence as a serious health issue.Summary
Aotearoa New Zealand has approved its first medically approved product designed to help individuals quit vaping. This approval signifies a crucial step in acknowledging vaping dependence as a genuine health issue requiring clinical care, rather than simply a consumer choice. The product is specifically designed to address the high-frequency, high-dose nicotine exposure characteristic of vaping, offering a gradual nicotine reduction under clinical supervision. While the Foundation welcomes this development, they emphasize the need for wider access, affordability, and integration with existing public health initiatives, including education, prevention, and stronger regulations on marketing and product availability, particularly to protect rangatahi (youth). They advocate for the product to be available through primary care, schools, and community providers, potentially with subsidies, to ensure equitable access.
(Source：Waatea News)
